Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

Effect of long-term clarithromycin therapy on prevention of pneumonia in older adults: A randomized, controlled trial.

Yamasue M, Komiya K, Yoshikawa H, Kohno Y, Imamura Y, Otani S, Shigenaga T, Koga H, Kishi K, Ichimiya T, Tanaka H, Hara K, Noguchi S, Yatera K, Mukae H, Hiramatsu K, Kadota JI.

Geriatr Gerontol Int. 2019 Oct;19(10):1006-1009. doi: 10.1111/ggi.13760. Epub 2019 Aug 15.

PMID:
31415123
2.

The impact of performance status on tuberculosis-related death among elderly patients with lung tuberculosis: A competing risk regression analysis.

Honjo K, Komiya K, Kan T, Uchida S, Goto A, Takikawa S, Yoshimatsu T, Wong ZSY, Takahashi O, Kadota JI.

J Infect Chemother. 2019 Jul 30. pii: S1341-321X(19)30212-0. doi: 10.1016/j.jiac.2019.07.008. [Epub ahead of print]

PMID:
31375456
3.

Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.

Sakamoto N, Hara S, Ishimoto H, Nakashima S, Yura H, Miyamura T, Okuno D, Hara A, Kakugawa T, Yamaguchi H, Obase Y, Kushima H, Ishii H, Noguchi S, Kido T, Kobayashi T, Soejima Y, Yoshioka S, Ishimatsu Y, Yatera K, Kadota JI, Mukae H.

Tohoku J Exp Med. 2019 Jul;248(3):209-216. doi: 10.1620/tjem.248.209.

4.

Factors associated with atypical radiological findings of pulmonary tuberculosis.

Goto A, Komiya K, Kan T, Honjo K, Uchida S, Takikawa S, Yoshimatsu T, Fujimoto K, Johkoh T, Kadota JI.

PLoS One. 2019 Jul 25;14(7):e0220346. doi: 10.1371/journal.pone.0220346. eCollection 2019.

5.

Pleural Effusion Due to Adult T Cell Leukemia.

Hashimoto T, Sasaki H, Ando M, Kadota JI.

Intern Med. 2019 Jul 10. doi: 10.2169/internalmedicine.3144-19. [Epub ahead of print] No abstract available.

6.

Asthma Exacerbation Coincident with Saddle Pulmonary Embolism and Paradoxical Embolism.

Hashimoto T, Ando M, Kan T, Fujishima N, Yamasue M, Komiya K, Umeki K, Nureki SI, Kadota JI.

Tohoku J Exp Med. 2019 Jun;248(2):137-141. doi: 10.1620/tjem.248.137.

7.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
8.

Impact of additional antibiotics on in-hospital mortality in tuberculosis isolated general bacteria: A propensity score analysis.

Kan T, Komiya K, Honjo K, Uchida S, Goto A, Kawano H, Takikawa S, Yoshimatsu T, Kadota JI.

J Infect Chemother. 2019 Sep;25(9):714-719. doi: 10.1016/j.jiac.2019.03.022. Epub 2019 Apr 11.

PMID:
30982726
9.

Mycobacterium tuberculosis Arising in a Solitary Pulmonary Cyst.

Ando M, Fujishima N, Matsumoto H, Kadota JI.

Intern Med. 2019 Jun 15;58(12):1803-1804. doi: 10.2169/internalmedicine.2380-18. Epub 2019 Feb 25. No abstract available.

10.

The heterogeneous effect of short-term transfers for improving ART adherence among HIV-infected Tanzanian adults

Kadota JL, Fahey CA, Njau PF, Kapologwe N, Padian NS, Dow WH, McCoy SI.

AIDS Care. 2018;30(Suppl 3):18-26. doi: 10.1080/09540121.2018.1476666. Epub 2018 Jul 8.

11.

Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell transplantation - Clues to a potential mechanism.

Oo ZP, Bychkov A, Zaizen Y, Yamasue M, Kadota JI, Fukuoka J.

Respir Med Case Rep. 2019 Feb 4;26:244-247. doi: 10.1016/j.rmcr.2019.02.001. eCollection 2019.

12.

A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis.

Fujishima N, Komiya K, Matsunaga N, Usagawa Y, Yamasue M, Hashinaga K, Umeki K, Nureki SI, Ando M, Matsunaga T, Kadota JI.

Intern Med. 2019;58(2):263-266. doi: 10.2169/internalmedicine.1369-18. Epub 2018 Jan 15.

13.

Early linear growth retardation: results of a prospective study of Zambian infants.

Chilengi R, Asombang M, Kadota JL, Chilyabanyama ON, Mwila-Kazimbaya K, Ng'ombe H, Simuyandi M, Bosomprah S.

BMC Public Health. 2019 Jan 14;19(1):61. doi: 10.1186/s12889-019-6411-3.

14.

A mini systematic review of prognostic factors in elderly patients with tuberculosis.

Uchida S, Komiya K, Honjo K, Umeki K, Nureki SI, Takikawa S, Ando M, Hiramatsu K, Kadota JI.

Respir Investig. 2019 May;57(3):207-212. doi: 10.1016/j.resinv.2018.12.004. Epub 2019 Jan 11. Review.

PMID:
30639081
15.

The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis.

Ando M, Ono T, Usagawa Y, Yoshikawa H, Hirano T, Tokimatsu I, Kadota JI.

J Infect Chemother. 2019 Feb;25(2):147-150. doi: 10.1016/j.jiac.2018.07.011. Epub 2018 Aug 7.

PMID:
30097373
16.

A case of maoto-induced interstitial pneumonia.

Ando M, Masuda T, Yamasue M, Nureki SI, Miyazaki E, Kadota JI.

J Thorac Dis. 2018 Jun;10(6):E485-E489. doi: 10.21037/jtd.2018.05.82.

17.

Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis.

Ando M, Goto A, Takeno Y, Yamasue M, Komiya K, Umeki K, Nureki SI, Miyazaki E, Kadota JI.

Clin Rheumatol. 2018 Oct;37(10):2833-2838. doi: 10.1007/s10067-018-4183-2. Epub 2018 Jun 23.

PMID:
29936689
18.

Decreasing Use of Percutaneous Endoscopic Gastrostomy Tube Feeding in Japan.

Komiya K, Usagawa Y, Kadota JI, Ikegami N.

J Am Geriatr Soc. 2018 Jul;66(7):1388-1391. doi: 10.1111/jgs.15386. Epub 2018 May 25.

PMID:
29799111
19.

The scab-like sign: A CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis?

Sato H, Okada F, Matsumoto S, Mori H, Kashiwagi J, Komatsu E, Maeda T, Nishida H, Daa T, Ohtani S, Umeki K, Ando M, Kadota J.

Eur Radiol. 2018 Oct;28(10):4053-4061. doi: 10.1007/s00330-018-5434-y. Epub 2018 May 3.

PMID:
29725831
20.

[National Trends in the Distribution of Candida Species Causing Candidemia in Japan from 2003 to 2014].

Kakeya H, Yamada K, Kaneko Y, Yanagihara K, Tateda K, Maesaki S, Takesue Y, Tomono K, Kadota JI, Kaku M, Miyazaki Y, Kamei K, Shibuya K, Niki Y, Yoshida M, Sei Y.

Med Mycol J. 2018;59(1):E19-E22. doi: 10.3314/mmj.17-00014. Japanese.

21.

Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.

Otani S, Hiramatsu K, Hashinaga K, Komiya K, Umeki K, Kishi K, Kadota JI.

J Infect Chemother. 2018 Jun;24(6):428-433. doi: 10.1016/j.jiac.2018.01.007. Epub 2018 Feb 12.

PMID:
29449129
22.

Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance.

Suzuki K, Kurashima A, Tatsuno K, Kadota JI.

Respir Investig. 2018 Jan;56(1):87-93. doi: 10.1016/j.resinv.2017.11.001. Epub 2017 Dec 6.

PMID:
29325687
23.

Optimal Trough Concentration of Teicoplanin in Febrile Neutropenic Patients with Hematological Malignancy.

Sato Y, Hiramatsu K, Suzuki Y, Tanaka R, Kaneko T, Nonoshita K, Ogata M, Kadota JI, Itoh H.

Chemotherapy. 2018;63(1):29-34. doi: 10.1159/000481725. Epub 2017 Nov 24.

PMID:
29169153
24.

Tiotropium inhibits mucin production stimulated by neutrophil elastase but not by IL-13.

Komiya K, Kawano S, Suzaki I, Akaba T, Kadota JI, Rubin BK.

Pulm Pharmacol Ther. 2018 Feb;48:161-167. doi: 10.1016/j.pupt.2017.11.008. Epub 2017 Nov 20.

PMID:
29158154
25.

The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.

Yatera K, Umeki K, Yamasaki K, Noguchi S, Nishida C, Ishimoto H, Sakamoto N, Ishii H, Kadota JI, Mukae H.

Respir Investig. 2017 Nov;55(6):380-383. doi: 10.1016/j.resinv.2017.07.005. Epub 2017 Sep 23. No abstract available.

PMID:
29153420
26.

PR3-ANCA-positive Pulmonary Cryptococcosis.

Goto A, Ando M, Usagawa Y, Kadota JI.

Intern Med. 2017 Dec 1;56(23):3265-3266. doi: 10.2169/internalmedicine.8925-17. Epub 2017 Oct 11. No abstract available.

27.

Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.

Yamasue M, Nureki SI, Usagawa Y, Ono T, Matsumoto H, Kan T, Kadota JI.

Tohoku J Exp Med. 2017 Sep;243(1):77-83. doi: 10.1620/tjem.243.77.

28.

Sensitive and selective quantification of total and free itraconazole and hydroxyitraconazole in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.

Suzuki Y, Tanaka R, Oyama N, Nonoshita K, Hashinaga K, Umeki K, Sato Y, Hiramatsu K, Kadota JI, Itoh H.

Clin Biochem. 2017 Dec;50(18):1228-1236. doi: 10.1016/j.clinbiochem.2017.09.011. Epub 2017 Sep 18.

PMID:
28928005
29.

Eosinophilic Bronchiolitis.

Sato H, Okada F, Matsumoto S, Ono A, Nakayama T, Mori H, Ono T, Usagawa Y, Kadota J.

J Thorac Imaging. 2017 Nov;32(6):W87-W89. doi: 10.1097/RTI.0000000000000302. No abstract available.

PMID:
28914741
30.
31.

A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema.

Komiya K, Akaba T, Kozaki Y, Kadota JI, Rubin BK.

Crit Care. 2017 Aug 25;21(1):228. doi: 10.1186/s13054-017-1809-8. Review.

32.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2017 Sep;23(9):587-597. doi: 10.1016/j.jiac.2017.05.010. Epub 2017 Jun 29.

PMID:
28669567
33.

Pulmonary-Limited Granulomatosis with Polyangiitis Coexisting with Mixed Connective Tissue Disease.

Ando M, Goto A, Yamasue M, Usagawa Y, Oka H, Shigenaga T, Kadota JI.

Tohoku J Exp Med. 2017 Jun;242(2):109-114. doi: 10.1620/tjem.242.109.

34.

A Prospective Study of the Efficacy, Safety and Pharmacokinetics of Enteral Moxifloxacin in the Treatment of Hemodialysis Patients with Pneumonia.

Tokimatsu I, Shigemura K, Kotaki T, Yoshikawa H, Yamamichi F, Tomo T, Arakawa S, Fujisawa M, Kadota JI.

Intern Med. 2017;56(11):1315-1319. doi: 10.2169/internalmedicine.56.8369. Epub 2017 Jun 1.

35.

Pulmonary Cryptococcosis Complicated by Sarcoidosis.

Nureki SI, Miyazaki E, Tokunaga YI, Kadota JI.

Intern Med. 2017;56(10):1265-1266. doi: 10.2169/internalmedicine.56.7764. Epub 2017 May 15. No abstract available.

36.

Pneumonia Severity Assessment Tools for Predicting Mortality in Patients with Healthcare-Associated Pneumonia: A Systematic Review and Meta-Analysis.

Noguchi S, Yatera K, Kawanami T, Fujino Y, Moro H, Aoki N, Komiya K, Kadota JI, Shime N, Tsukada H, Kohno S, Mukae H.

Respiration. 2017;93(6):441-450. doi: 10.1159/000470915. Epub 2017 Apr 28. Review.

37.

Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society].

Tokuda H, Harigai M, Kameda H, Tomono K, Takayanagi N, Watanabe A, Tasaka S, Suda T, Tateda K, Kadota J.

Respir Investig. 2017 May;55(3):229-251. doi: 10.1016/j.resinv.2017.01.002. Epub 2017 Mar 29. Review. No abstract available.

PMID:
28427750
38.

Pulmonary Sarcoidosis Presenting with Thin-walled Small Cysts.

Kushima H, Ishii H, Kadota JI, Watanabe K.

Intern Med. 2017;56(8):985-986. doi: 10.2169/internalmedicine.56.7766. Epub 2017 Apr 15. No abstract available.

39.

The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.

Ohta S, Okamoto M, Fujimoto K, Sakamoto N, Takahashi K, Yamamoto H, Kushima H, Ishii H, Akasaka K, Ono J, Kamei A, Azuma Y, Matsumoto H, Yamaguchi Y, Aihara M, Johkoh T, Kawaguchi A, Ichiki M, Sagara H, Kadota JI, Hanaoka M, Hayashi SI, Kohno S, Hoshino T, Izuhara K; Consortium for Development of Diagnostics for Pulmonary Fibrosis Patients (CoDD-PF).

PLoS One. 2017 Mar 29;12(3):e0174547. doi: 10.1371/journal.pone.0174547. eCollection 2017.

40.

The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.

Kadota JI, Kurashima A, Suzuki K.

J Infect Chemother. 2017 May;23(5):293-300. doi: 10.1016/j.jiac.2017.01.007. Epub 2017 Feb 27.

PMID:
28254517
41.

A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.

Kushima H, Tokimatsu I, Ishii H, Kawano R, Watanabe K, Kadota JI.

Med Mycol J. 2017;58(1):E23-E28. doi: 10.3314/mmj.16-00027.

42.

Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts.

Komiya K, Ohta S, Arima K, Ogawa M, Suzuki S, Mitamura Y, Nunomura S, Nanri Y, Yoshihara T, Kawaguchi A, Kadota JI, Rubin BK, Izuhara K.

Respir Res. 2017 Feb 20;18(1):37. doi: 10.1186/s12931-017-0519-8.

43.

Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: A systematic review with meta-analysis.

Komiya K, Rubin BK, Kadota JI, Mukae H, Akaba T, Moro H, Aoki N, Tsukada H, Noguchi S, Shime N, Takahashi O, Kohno S.

Sci Rep. 2016 Dec 7;6:38097. doi: 10.1038/srep38097. Review.

44.

Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014.

Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, Kadota J, Kamei K, Kanda Y, Kiuchi T, Shibuya K, Takakura S, Takata T, Takesue Y, Teruya K, Tokimatsu I, Fukuda T, Maesaki S, Makimura K, Mikamo H, Mitsutake K, Miyazaki Y, Mori M, Yasuoka A, Yano K, Yamanaka N, Yoshida M.

Med Mycol J. 2016;57(4):E117-E163. Review. No abstract available.

45.

A Retrospective Analysis of Risk Factors for Linezolid-Associated Hyponatremia in Japanese Patients.

Tanaka R, Suzuki Y, Takumi Y, Iwao M, Sato Y, Hashinaga K, Hiramatsu K, Kadota JI, Itoh H.

Biol Pharm Bull. 2016;39(12):1968-1973.

46.

Disseminated Mycobacterium tuberculosis Infection Masquerading as Metastasis after Heavy Ion Radiotherapy for Prostate Cancer.

Ando M, Mukai Y, Ushijima RI, Shioyama Y, Umeki K, Okada F, Nureki SI, Mimata H, Kadota JI.

Intern Med. 2016;55(22):3387-3392. Epub 2016 Nov 15.

47.

Familial Mediterranean Fever with Rheumatoid Arthritis Complicated by Pulmonary Paragonimiasis.

Nureki SI, Ishii K, Fujisaki H, Torigoe M, Maeshima K, Shibata H, Miyazaki E, Kadota JI.

Intern Med. 2016;55(19):2889-2892. Epub 2016 Oct 1.

48.

Angiopoietin-2 expression in patients with an acute exacerbation of idiopathic interstitial pneumonias.

Ando M, Miyazaki E, Abe T, Ehara C, Goto A, Masuda T, Nishio S, Fujisaki H, Yamasue M, Ishii T, Mukai Y, Ito T, Nureki SI, Kumamoto T, Kadota J.

Respir Med. 2016 Aug;117:27-32. doi: 10.1016/j.rmed.2016.05.012. Epub 2016 May 24.

49.

Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.

Yoshioka D, Kajiwara C, Ishii Y, Umeki K, Hiramatsu K, Kadota J, Tateda K.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6146-54. doi: 10.1128/AAC.01024-16. Print 2016 Oct.

50.

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.

Takahashi S, Hamasuna R, Yasuda M, Ishikawa K, Hayami H, Uehara S, Yamamoto S, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Masumori N, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Wada K, Kobayashi K, Matsubara A, Matsumoto T, Eto M, Tatsugami K, Kuroiwa K, Ito K, Hosobe T, Hirayama H, Narita H, Yamaguchi T, Ito S, Sumii T, Kawai S, Kanokogi M, Kawano H, Chokyu H, Uno S, Monden K, Kaji S, Kawahara M, Takayama K, Ito M, Yoshioka M, Kano M, Konishi T, Kadena H, Nishi S, Nishimura H, Yamauchi T, Maeda S, Horie M, Ihara H, Matsumura M, Shirane T, Takeyama K, Akiyama K, Takahashi K, Ikuyama T, Inatomi H, Yoh M.

J Infect Chemother. 2016 Sep;22(9):581-6. doi: 10.1016/j.jiac.2016.06.010. Epub 2016 Jul 21.

PMID:
27452428

Supplemental Content

Loading ...
Support Center